Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

DE NOVO PHARMACEUTICALS LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Book a Demo now

Financial statements of DE NOVO PHARMACEUTICALS LIMITED

According to DE NOVO PHARMACEUTICALS LIMITED latest financial report submitted on 2025-09-30, the company has a Total-Assets of £53,991.00, Working-Capital of £51,940.00 while the Total-Liabilities is £2,051.00. Compared with the previous year, the company reported a Total-Assets decrease of -14.2%, which is an equivalent of 7666. At the same time, the Working-Capital went down by -17.77%, or by 9232.


Year:
2024 Not available
2023 Not available
2022 Not available
2021 Not available

Access 20 Years of Financial Data

Book a Demo
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Profit after Tax

    £ -

  • Working Capital

    £ 51940

Profit after Tax

DE NOVO PHARMACEUTICALS LIMITED Business Credit Report

A Business Credit Report for DE NOVO PHARMACEUTICALS LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for DE NOVO PHARMACEUTICALS LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

DE NOVO PHARMACEUTICALS LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

DE NOVO PHARMACEUTICALS LIMITED Directors and key executives

DE NOVO PHARMACEUTICALS LIMITED currently employs 2 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees.
In order to view contact information, including emails and phone numbers for all the employees working at DE NOVO PHARMACEUTICALS LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

2

100%

1y growth

100%

2y growth

Management Level


17

Top

67

Middle

Employee Job Title Email Phone Country
Frederick Fahid Director
-
- GB
Nikolay Todorov Principal Scientist
-
- GB
Steve Beasley Chief Business Officer
-
- GB
Graham Trott Senior Programmer
-
- GB
Farhad Fahid Director
-
- GB

Get direct emails & phone numbers for senior executives working at «DE NOVO PHARMACEUTICALS LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

DE NOVO PHARMACEUTICALS LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Book a Demo

DE NOVO PHARMACEUTICALS LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at DE NOVO PHARMACEUTICALS LIMITED. One of of major shareholders of DE NOVO PHARMACEUTICALS LIMITED is FARHAD FRED FAHID, which owns 16408655600 ORDINARY shares, with a total value of 0 GBP and ARI HOLDINGS GROUP LIMITED (ARIL) C/O TRIDENT TRUST COMPANY (B.V.I.) LIMITED, which owns 3714225331 ORDINARY shares, with a total value of 0 GBP and ROXANNA FAHID, which owns 3710905899 ORDINARY shares, with a total value of 0 GBP and CLEWLOW BUNN LIMITED, which owns 3646367911 ORDINARY shares, with a total value of 0 GBP and SHADI FEIZ, which owns 3581379384 ORDINARY shares, with a total value of 0 GBP.


Name Quantity Share Type Value
FARHAD FRED FAHID
16408655600 ORDINARY 0 GBP
ARI HOLDINGS GROUP LIMITED (ARIL) C/O TRIDENT TRUST COMPANY (B.V.I.) LIMITED
3714225331 ORDINARY 0 GBP
ROXANNA FAHID
3710905899 ORDINARY 0 GBP
CLEWLOW BUNN LIMITED
3646367911 ORDINARY 0 GBP
SHADI FEIZ
3581379384 ORDINARY 0 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

DE NOVO PHARMACEUTICALS LIMITED competitors:

Top 5 similar companies of DE NOVO PHARMACEUTICALS LIMITED are TIZIANA LIFE SCIENCES LIMITED, TSP ADVANCED TECHNOLOGIES PLC, SYNAIRGEN LIMITED, EDEN RESEARCH PLC, SAREUM HOLDINGS PLC. View and export all the competitor list of DE NOVO PHARMACEUTICALS LIMITED by upgrading your account here.


TIZIANA LIFE SCIENCES LIMITED


Revenue
-
Age
28 years
Employees
9
Industry
View Scientific & Education
Website
View https://www.tizianalifes**********************

TSP ADVANCED TECHNOLOGIES PLC


Revenue
-
Age
12 years
Employees
2
Industry
View Scientific & Education
Website
View https://www.t************

SYNAIRGEN LIMITED


Revenue
-
Age
22 years
Employees
36
Industry
View Scientific & Education
Website
View http://www.sy************

EDEN RESEARCH PLC


Revenue
4,852,265.0
Age
31 years
Employees
5
Industry
View Scientific & Education
Website
View http://www.eden*************

SAREUM HOLDINGS PLC


Revenue
-
Age
22 years
Employees
5
Industry
View Scientific & Education
Website
View http://www.s**********

View & Export DE NOVO PHARMACEUTICALS LIMITED competitors:

Get the complete list with detailed profiles

Book a Demo

DE NOVO PHARMACEUTICALS LIMITED news & activities:


Employees

DE NOVO PHARMACEUTICALS LIMITED number of employees has decreased by 0% compared with previous year and now represents a total number of 2.

uk.globaldatabase.com

2025-09-30

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Book a Demo

Frequently Asked Questions regarding DE NOVO PHARMACEUTICALS LIMITED


Where is DE NOVO PHARMACEUTICALS LIMITED registered office?

DE NOVO PHARMACEUTICALS LIMITED is located at Gilmarde House 47 South Bar Street, United Kingdom.

How many people work at DE NOVO PHARMACEUTICALS LIMITED?

According to the latest account statement, there are currently 2 of employees working for DE NOVO PHARMACEUTICALS LIMITED.

What is the Business Credit Score of DE NOVO PHARMACEUTICALS LIMITED and how reliable is the company?

In order to check the business credit score of DE NOVO PHARMACEUTICALS LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does DE NOVO PHARMACEUTICALS LIMITED pay their invoices on time?

By requesting a Business Credit Report for DE NOVO PHARMACEUTICALS LIMITED, you will be able to gain more insights about the DE NOVO PHARMACEUTICALS LIMITED payment trends.

Who is the Ultimate Parent of the DE NOVO PHARMACEUTICALS LIMITED?

Information about the ultimate beneficial ownership MERLIN RESIDUAL *************** of DE NOVO PHARMACEUTICALS LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action